long-term effects of glp-1 drugs long term TrimRX The GLP-1 Agonists and Obesity:

doi: 10.1186/1742-2094-9-276 10 NauckMAQuastDRWefersJMeierJJ

So, we have seen successful GLP-1 drugs receive warnings years after being on the market for previously unknown side effects, in both an older and newer GLP-1 drugs

Prescription drugs segment is slated to dominate the industry, accounting for nearly two-thirds of the global anti-obesity drug market share by 2025

These ancillary costs add 15-25% on top of the peptide price itself

FDA approved long-acting GLP-1 receptor agonists include: Exenatide extended-release (Bydureon) Dulaglutide (Trulicity) Semaglutide (Ozempic, see Important Safety Information

As with other GLP-1 medicines, people with: A history of severe gastrointestinal disease Pancreatitis Significant kidney or liver issues should only use GLP-1 treatments under close clinical monitoring